eHealth Inc

EHTH is in a Stage 4 decline with confirmed lower highs and lower lows, trading below declining EMAs that act as resistance. Medium-term asymmetry remains bearish, and short-term timing is bearish as price tightly tracks under sloping EMAs. Execution should occur now via a rejection at the 9/20/50 EMA cluster. A sustained close and acceptance above the EMA zone and a subsequent higher swing high would invalidate this bearish medium-term bias.

• ↑FY25 revenue guidance of $525–565 M indicates strong growth trajectory.
• ↑Targeted $30 M fixed cost cuts for 2026 improve operating leverage.
• ↓Q1’26 revenue declined 22% YoY to $88 M with a net loss of $4.7 M.